MDT

96.67

+0.59%↑

A

137.56

-0.2%↓

VEEV

224.65

-0.07%↓

HQY

91.97

-0.76%↓

PHR.US

17

+0.18%↑

MDT

96.67

+0.59%↑

A

137.56

-0.2%↓

VEEV

224.65

-0.07%↓

HQY

91.97

-0.76%↓

PHR.US

17

+0.18%↑

MDT

96.67

+0.59%↑

A

137.56

-0.2%↓

VEEV

224.65

-0.07%↓

HQY

91.97

-0.76%↓

PHR.US

17

+0.18%↑

MDT

96.67

+0.59%↑

A

137.56

-0.2%↓

VEEV

224.65

-0.07%↓

HQY

91.97

-0.76%↓

PHR.US

17

+0.18%↑

MDT

96.67

+0.59%↑

A

137.56

-0.2%↓

VEEV

224.65

-0.07%↓

HQY

91.97

-0.76%↓

PHR.US

17

+0.18%↑

Search

AtriCure Inc

Cerrado

SectorSanidad

40.14 -0.47

Resumen

Variación precio

24h

Actual

Mínimo

39.5

Máximo

40.41

Métricas clave

By Trading Economics

Ingresos

5.9M

-267K

Ventas

-1.9M

134M

Margen de beneficios

-0.199

Empleados

1,300

EBITDA

7.3M

8M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+28.51% upside

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

205M

2.1B

Apertura anterior

40.61

Cierre anterior

40.14

Noticias sobre sentimiento de mercado

By Acuity

43%

57%

134 / 374 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bearish Evidence

AtriCure Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

29 dic 2025, 22:03 UTC

Principales Movimientos del Mercado

Mining Stocks Slip Near the End of Stellar Year

29 dic 2025, 15:57 UTC

Principales Movimientos del Mercado

Praxis Shares Rise on Ulixacaltamide Breakthrough Designation

29 dic 2025, 23:43 UTC

Charlas de Mercado

Nikkei May Decline; Yen in Focus -- Market Talk

29 dic 2025, 23:38 UTC

Adquisiciones, fusiones, absorciones

Manus: Will Continue to Operate From Singapore

29 dic 2025, 23:38 UTC

Adquisiciones, fusiones, absorciones

Manus: Will Continue to Sell, Operate Product Subscription Service Through App, Website

29 dic 2025, 23:37 UTC

Adquisiciones, fusiones, absorciones

Meta Platforms: Will Integrate Manus Service Into Products

29 dic 2025, 23:36 UTC

Adquisiciones, fusiones, absorciones

Meta Platforms: Will Continue to Operate, Sell Manus Service

29 dic 2025, 23:36 UTC

Adquisiciones, fusiones, absorciones

Meta Platforms: Manus's Talent to Join Team to Deliver General-Purpose Agents Across Consumer, Business Products

29 dic 2025, 23:35 UTC

Adquisiciones, fusiones, absorciones

Manus to Join Meta Platforms

29 dic 2025, 21:33 UTC

Adquisiciones, fusiones, absorciones

Origin: Raise Values Kraken at US$8.65 Billion

29 dic 2025, 21:33 UTC

Adquisiciones, fusiones, absorciones

Origin: Octopus Targeting Kraken Separation by Mid 2026

29 dic 2025, 21:31 UTC

Adquisiciones, fusiones, absorciones

BlueScope: Rezoning Will Allow for Range of Commercial, Industrial Development Uses

29 dic 2025, 21:31 UTC

Adquisiciones, fusiones, absorciones

BlueScope Also Says Land Adjacent to Port Kembla Steelworks Rezoned to Special Purpose

29 dic 2025, 21:30 UTC

Adquisiciones, fusiones, absorciones

Origin's Kraken Stake to Remain at 22.7%

29 dic 2025, 21:30 UTC

Adquisiciones, fusiones, absorciones

Origin Will Continue to Hold Its 22.7% Interest in Octopus

29 dic 2025, 21:30 UTC

Adquisiciones, fusiones, absorciones

BlueScope: Guidance Reflects Sustained Strength of Operating Performance in Recent Months

29 dic 2025, 21:30 UTC

Adquisiciones, fusiones, absorciones

Origin: Additional Interest Offsets Dilution From Raise

29 dic 2025, 21:30 UTC

Adquisiciones, fusiones, absorciones

BlueScope Doesn't Expect Material Impact on 1H Guidance Range

29 dic 2025, 21:29 UTC

Adquisiciones, fusiones, absorciones

Origin Waiving Australia Exclusivity to Kraken in Exchange for Additional 1.5% Equity Interest

29 dic 2025, 21:29 UTC

Adquisiciones, fusiones, absorciones

BlueScope Expects to Complete Property Sale for A$76 Million Consideration

29 dic 2025, 21:29 UTC

Adquisiciones, fusiones, absorciones

BlueScope Expects to Complete Property Sale in 2H of FY 2026

29 dic 2025, 21:28 UTC

Adquisiciones, fusiones, absorciones

BlueScope: Selling Residentially Zoned Land in West Dapto to Large Homebuilder

29 dic 2025, 21:28 UTC

Adquisiciones, fusiones, absorciones

Origin: Kraken's Raise Paves Way for Separation From Octopus Energy

29 dic 2025, 21:28 UTC

Adquisiciones, fusiones, absorciones

Origin: Kraken to Raise Total US$1 Billion From New, Existing Investors

29 dic 2025, 21:28 UTC

Adquisiciones, fusiones, absorciones

BlueScope Steel Exchanges Contracts for Sale of 33 Hectares of Land in West Dapto

29 dic 2025, 21:27 UTC

Adquisiciones, fusiones, absorciones

Origin Energy to Invest US$140M in Kraken's Standalone Equity Raise

29 dic 2025, 20:22 UTC

Charlas de Mercado

Oil Rebounds As Russia-Ukraine War Seen Continuing -- Market Talk

29 dic 2025, 20:14 UTC

Charlas de Mercado

U.S. Natural Gas Futures Rise As Front Month Expires -- Market Talk

29 dic 2025, 20:02 UTC

Adquisiciones, fusiones, absorciones

Union Pacific--Norfolk Southern Merger Targets Trucking Market Share -- Barrons.com

29 dic 2025, 17:36 UTC

Charlas de Mercado

U.S. Natural Gas Inventories Swing to Deficit Vs. 5-Year Average -- Market Talk

Comparación entre iguales

Cambio de precio

AtriCure Inc previsión

Precio Objetivo

By TipRanks

28.51% repunte

Estimación a 12 Meses

Media 51.83 USD  28.51%

Máximo 64 USD

Mínimo 45 USD

De acuerdo con 6 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para AtriCure Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

6 ratings

6

Comprar

0

Mantener

0

Vender

Puntuación técnica

By Trading Central

30.36 / 33.4Soporte y Resistencia

Corto Plazo

Strong Bearish Evidence

Medio plazo

Strong Bearish Evidence

Largo Plazo

Strong Bearish Evidence

Sentimiento

By Acuity

134 / 374 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de AtriCure Inc

AtriCure, Inc. develops, manufactures, and sells devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, Europe, the Asia-Pacific, and internationally. The company offers Isolator Synergy Clamps, single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation, and ablate cardiac tissue with the same device; and the Coolrail device, which enables users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Systems, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; cryoSPHERE probe, which provides temporary pain relief by applying cryothermic energy to targeted intercoastal peripheral nerves in the ribcage; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure. In addition, the company sells Lumitip dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.